InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,792.80
(
0.00%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.31
(
-0.34%
)
Bitcoin
62,855.83
(
3.41%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

opportunityknocking

Send PM Follow Ignore
Followers 2
Posts 927
Boards Moderated 0
Alias Born 09/27/2005

opportunityknocking

Re: bob10131 post# 14813

Tuesday, 07/08/2008 12:33:26 PM

Tuesday, July 08, 2008 12:33:26 PM

Post# of 30387
Here is my 2 cents on the approval. First thing I noticed it is an ELISA test (Dr Moro's recent press release about our new ELISA test is not a coincidence). Secondly, their approval bodes very well for us. Third, it is to be used with persons ALREADY DIAGNOSED with colorectal cancer. Fourth, it is to be used in conjunction with other clinical modalities that are within the standard of care.

It would appear that Recaf will be approved under the same restrictions at first, but IMO, WE will be the standard of care.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up